Illinois Gov. JB Pritzker disclosed for the first time that he lost 80 pounds using a GLP-1 weight-loss drug, a personal revelation that arrives as the billionaire Democrat weighs a potential 2028 White House bid.
Pritzker made the announcement during a CBS Mornings interview that aired Monday, publicly confirming what political observers had noticed for months: the governor's frame had changed dramatically. He had dodged questions about his weight loss for roughly a year before finally going on the record, Breitbart reported.
The timing raises an obvious question. Pritzker is not just a sitting governor discussing a health decision. He is a Democrat who has refused to rule out a 2028 presidential run, and his transformation, paired with a previously undisclosed diabetes diagnosis, looks less like a casual health update and more like a carefully staged rollout for a national audience.
Pritzker revealed during the CBS interview that he was diagnosed with diabetes two years ago, a condition he had never previously disclosed to the public. The GLP-1 medication, which he injects weekly, was prescribed in connection with that diagnosis and helped drive his 80-pound loss over a two-year period, Just The News reported.
GLP-1 drugs work by mimicking a hormone that stimulates insulin secretion and reduces appetite. A Gallup survey published in July found a record 11 percent of Americans now use a GLP-1 medication for weight loss, an eight-point jump from 2024.
The Hill reported Pritzker's own words about the personal significance of the drug:
"The fact that I am now able to do it because this GLP-1 became available is truly, like, I mean, it's something that has meant a lot to me."
He also said he felt a lifelong pressure around his weight: "I have been driven my whole life to lose weight." The governor cited his father's fatal heart attack as part of his motivation, the New York Post reported.
Pritzker's personal use of the drug coincides with a policy decision that carries a significant price tag. Illinois expanded GLP-1 coverage beyond diabetes patients in July 2024, extending it to state employees seeking weight-loss treatment. The state now covers these drugs for roughly 55,000 state employees at a cost of $147 million in fiscal year 2025.
Pritzker framed the expansion as a public-health opportunity, not a personal benefit. He told CBS Mornings he wanted to use his platform to encourage others:
"I have an opportunity, just with the platform I have as governor, to tell people that this is something that can work for them."
But the sequence matters. A governor who was privately using a GLP-1 drug expanded taxpayer-funded access to the same class of medication, then waited more than a year to tell the public he was on it. That is not transparency. That is disclosure management.
Illinois taxpayers might reasonably ask whether the $147 million coverage expansion was driven by sound public-health analysis or by a governor's personal enthusiasm for a drug he was already taking. The fact that Pritzker kept both his diabetes diagnosis and his drug use private while making that policy choice does not inspire confidence in the process.
When pressed about a potential presidential campaign, Pritzker offered the kind of non-denial that political watchers have learned to read as a soft yes. He told CBS Mornings he had "not made any decisions about what I might do in the future" and added that he is "honestly focused on what's best for the people of Illinois." The Washington Examiner noted that Pritzker is simultaneously considering a third term as governor and a 2028 presidential bid.
The physical transformation, the national television appearance, the carefully timed personal story, none of this is accidental. Democrats who have watched their party struggle to find a viable 2028 contender will recognize the playbook. Pritzker is building a narrative: a man who overcame a health challenge, made a difficult personal change, and wants to bring that same determination to a larger stage.
Whether the Democratic base will rally behind a billionaire governor from a deep-blue state is another matter entirely. The party's recent history of internal fractures over its own primary process suggests that a coronation-style candidacy would face resistance from the progressive wing.
Pritzker's weight has been a subject of public commentary before, including from President Trump. Trump previously said Pritzker "ought to spend more time in the gym, actually" and accused the governor of being "too busy eating" to lead his state. Neither comment was dated in the available reporting, but both preceded Pritzker's public disclosure.
In late August 2025, Pritzker fired back at Trump's remarks, calling them "just evidence of a guy who's still living in fifth grade." He also took a shot at Trump's own fitness, saying: "It takes one to know one, on the weight question. And the president, of course, himself, is not in good shape. So, he ought to respond to that from me."
Pritzker's decision to go public now, after losing 80 pounds and after those exchanges, gives the disclosure a distinctly political flavor. A governor who endured public ribbing about his weight for years chose to reveal his transformation on national television at the precise moment when 2028 positioning has begun in earnest.
Chicago, the city Pritzker governs from, has its own well-documented struggles. Even allies of the Democratic establishment have acknowledged the city's civic failures in recent years. Whether Pritzker's personal health story is enough to overshadow the policy record he would carry into a national race remains to be seen.
Several questions remain unanswered. Pritzker did not disclose which specific GLP-1 drug he uses, whether semaglutide, sold under the brand name Ozempic, or tirzepatide, marketed as Mounjaro, or another medication in the class. He did not say when exactly he began taking the drug, beyond the two-year timeframe implied by his diabetes diagnosis.
No independent medical confirmation of Pritzker's weight loss or diabetes diagnosis has been reported. Voters considering him as a potential presidential candidate would presumably want a fuller accounting of his health, the kind of disclosure that has become standard for serious White House contenders.
The broader pattern among Democratic leaders, keeping unflattering personal information private until the political moment demands a reveal, is not unique to Pritzker. But it does fit a familiar template. The question is whether voters will see a man who overcame a health challenge or a politician who managed the timing of his disclosures for maximum political advantage.
And for Illinois taxpayers footing a $147 million bill for state-employee GLP-1 coverage, the governor's year-long silence about his own use of the same drugs is not a minor detail. It is a conflict of interest that went unacknowledged until Pritzker decided the time was right to talk.
Losing 80 pounds takes discipline. So does timing a personal revelation to land at the exact moment it serves your political ambitions. Pritzker managed both, and voters should decide which one impresses them more.